ArticleActa parasitologica2026
Evaluation of biological and biochemical indicators associated with Toxoplasmosis in pregnant women.
Article in Acta parasitologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeToxoplasmosis is one of the most important parasitic factors causing miscarriage in pregnant women. This cross-sectional study was conducted to evaluate some hematological parameters and cytokine levels (IL-6 and IL-27) in women who had first-trimester miscarriage due to toxoplasmosis compared to the control group.
methodsFrom January to December 2023, 65 women in Al-Shamiya District, Diwaniyah Governorate, central Iraq, who had previously been diagnosed with toxoplasmosis through serological testing and experienced a first-trimester miscarriage, were the subject of the current study. As controls, there were twenty healthy, non-pregnant women. Laboratory tests were performed on venous blood samples in order to evaluate hematological parameters. The slide agglutination test was also used to identify blood types, and the ELISA test was used to measure the levels of the immunological markers interleukin-6 and interleukin-27.
resultsAccording to the current findings, a statistically significant association was found between blood type and toxoplasmosis incidence (χ² = 12.39, df = 3, P = 0.006). This indicates a genuine association between the two variables, particularly the higher incidence among individuals with blood type B. Laboratory tests confirmed statistically significant differences between the infected women and the control group in most of the analyzed blood parameters. A marked increase in total white blood cell count was observed, while the red blood cell count decreased. The effect size and 95% confidence intervals further support the statistical reliability of the pooled data. The results confirmed a statistically significant difference (p < 0.001) in interleukin-27 levels between the two study groups. However, the mean of 88 pg/mL in the abortion group and 73 pg/mL in the control group indicated a slight increase in serum interleukin-6 levels in the women who had abortions. No statistically significant differences were observed between the two groups (p ≈ 0.16) according to the Mann-Whitney U test used, due to the large variability in the results shown by the aborted animals.
conclusionsThe present findings represent preliminary evidence that warrants further research in order to understand the molecular or immunological mechanisms underlying the relationship between toxoplasmosis infection and hematologic parameters and immune markers among women with history of abortion. This will to help stratify the most at-risk people and establish better prevention and early detection in the future.
Indexed as
Identifiers
41670836What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.